Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
Front Immunol
; 12: 697405, 2021.
Article
in En
| MEDLINE
| ID: mdl-34220859
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Myeloid-Derived Suppressor Cells
/
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos